Conferences & Events

Why Your EHR is Blind to Your Biggest Supply Chain Risks (and how Dartmouth Health fixed it).

Join Quva and EDSA on April 28 at 11:00 AM CT to hear how Dartmouth Health connects procurement, pharmacy, and clinical teams using Quva BrightStream to improve drug shortage visibility and strengthen supply resiliency.

Register Now

Key questions answered:

1. Have you ever assessed the reliability of your supply chain partners?
   • Some suppliers are good at taking orders, but bad at fulfilling our orders. Without understanding the resiliency of your supply chain partners, it’s a cycle of disappointment that can impact patient care.
     
     
2. Can you tie your drug purchases to your medication use process?
   • When things are going well, this is not a problem. When disruptions occur, not knowing will create inefficiencies, impact your budget and force you to scramble for sub-optimal alternatives.
     
     
3. Are cyclical shortages burning you out?
   • If you've been in clinical practice long enough, you've seen this shortage before. 

Panelists:

• Michael P. Smith, PharmD, BCCCP — Dartmouth Health
• Eric Potrykus, PharmD, BCPS — Quva BrightStream

Moderator:

• Dwight deVera — VP, Healthcare Intelligence, Quva

Register Now

Typical Drug Shortage Wins By the Numbers:

If your drug shortage strategy relies on a spreadsheet, you aren't managing the shortage; you're just documenting the crisis.